DirectEffect
What is DirectEffect

1992 – 2009

Basic and clinical investigations aimed at developing effective HIV vaccines and improving AIDS treatment are conducted within the Christopher H. Browne Center for Immunology and Immune Diseases, an interactive consortium of world-class immunology labs at Rockefeller. With strengths in multiple areas of scientific inquiry, Rockefeller scientists are uniquely positioned to develop the new medical tools that will be needed to stem the global AIDS epidemic.

From 1992 to 2009, through volunteer-organized events, the DirectEffect HIV-AIDS Research Support Program raised funds to support this outstanding and innovative research on HIV and AIDS. The Rockefeller University remains grateful to the individuals, foundations, and corporations who generously contributed to DirectEffect.

Whether you are a longtime friend of DirectEffect or a curious newcomer, we invite you to support vaccine development at the University with a gift to the Steinman Vaccine Initiative for Cancer and HIV-AIDS Research.

Dendritic cell receptor may be the key to an HIV vaccine. Read more »

Researchers track down the location of HIV-1 assembly in human cells. Read more »

HIV-1 virus kills immune cells in the gut that may never bounce back. Read more »

Rockefeller researchers receive Gates Foundation grant for HIV vaccine research. Read more »

The Continuing Challenge of HIV-AIDS Research
Newswire
More News
Subscribe to Newswire via:

Subscribe to Newswire via Email   Subscribe to Newswire via RSS Help
For more information:

The Rockefeller University
1230 York Avenue, Box 164
New York, NY 10065
Phone: 212-327-8961
Fax: 212-327-7752
E-mail: ruc@rockefeller.edu

http://www.rockefeller.edu/